Have You Held Geron Stock Continuously Since March 2018?

Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is investigating whether certain officers and/or directors of Geron Corporation (“Geron”) (NASDAQ: GERN) breached their fiduciary duties to Geron and the Company’s shareholders. 

The investigation concerns whether certain officers and/or directors of Geron, among other things, made false and misleading statements about the effectiveness of the drug imetelstat.  Geron’s stock price dropped significantly when the company’s development partner, Janssen Biotech, pulled out of the imetelstat partnership on September 27, 2018, erasing hundreds of millions of dollars of shareholder value.

IF YOU HAVE HELD GERON STOCK CONTINUOUSLY SINCE AT LEAST MARCH 2018 AND WISH TO DISCUSS KEHOE LAW FIRM’S INVESTIGATION OR HAVE QUESTIONS ABOUT YOUR POTENTIAL LEGAL RIGHTS, PLEASE CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], [email protected], TO LEARN MORE ABOUT THE INVESTIGATION OR POTENTIAL LEGAL CLAIMS.

Kehoe Law Firm, P.C.